Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FKEKV
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,250
Award facts
- Contract value 100% obligated
- $16,249.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $16,249.95 delivery order to DMS Pharmaceutical Group Inc. on August 28, 2025, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price contract is set to conclude by September 19, 2025, with performance occurring at the vendor's location in Park Ridge, Illinois. The delivery order carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on the open market despite its status as a woman-owned small business.
DMS Pharmaceutical Group Inc., a pharmaceutical wholesaler based in Park Ridge, Illinois, secured this delivery order under its larger Indefinite Delivery Contract (IDC) with the DLA valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting military health facilities worldwide. Stelara, a biologic medication used for immunological conditions, represents one of many specialty pharmaceutical products within DMS Pharmaceutical Group's extensive federal contract portfolio. The vendor's robust track record in supplying branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites positions it as a critical supplier within the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB25FKEKV?
SPE2DB25FKEKV was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 28, 2025.
How much is contract SPE2DB25FKEKV worth?
The government has obligated $16,250 on SPE2DB25FKEKV.
Is contract SPE2DB25FKEKV an order under another contract?
Yes. SPE2DB25FKEKV is a delivery order under SPE2DB24D9223, an indefinite delivery contract.
Was contract SPE2DB25FKEKV competed?
The extent of competition for SPE2DB25FKEKV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award